Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000425425

Medchemexpress LLC Vapreotide acetate | 849479-74-9 | 98.2% | 1191.42 | 50 MG
SDP

Catalog No. 5000425425
Encompass_Preferred

Vapreotide acetate, also known as RC-160 acetate, is a neurokinin-1 (NK1) receptor antagonist. It inhibits Substance P (SP)-triggered intracellular calcium increases and NF-κB activation, making it suitable for various research applications in cell signaling and disease models.

  • Neurokinin-1 (NK1) receptor antagonist with an IC50 of 330 nM
  • Inhibits Substance P (SP)-induced IL-8 and MCP-1 production
  • Demonstrates activity against HIV-1 infection in human MDM in vitro
  • Effective in decreasing collateral circulation blood flow in cirrhosis in vivo
  • Reduces tumor volumes in prostate-cancer xenografts in nude mice

Catalog No. 50-004-25425 Supplier Medchemexpress LLC Supplier No. HYP0061A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Vapreotide acetate, also known as RC-160 acetate, is a neurokinin-1 (NK1) receptor antagonist. It inhibits Substance P (SP)-triggered intracellular calcium increases and NF-κB activation, making it suitable for various research applications in cell signaling and disease models.

  • Neurokinin-1 (NK1) receptor antagonist with an IC50 of 330 nM
  • Inhibits Substance P (SP)-induced IL-8 and MCP-1 production
  • Demonstrates activity against HIV-1 infection in human MDM in vitro
  • Effective in decreasing collateral circulation blood flow in cirrhosis in vivo
  • Reduces tumor volumes in prostate-cancer xenografts in nude mice

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.